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A B S T R A C T
Purpose: Troponins are very sensitive biomarkers of myocardial injury. Conﬂicting data regarding
elevation of troponin levels following a generalized tonic–clonic (GTC) seizure have been reported. In
this study we hypothesized that troponin elevation after a GTC seizure occurs more frequently in
patients with cardiovascular risk factors.
Methods: Patients who presented to the ER after a single GTC seizure with troponin levels assessed by
cardiac troponin T (cTnT) and drawn within 12 h of the GTC seizure were included. Patients with cardiac
symptoms, elevated CPK levels or renal insufﬁciency were excluded. The frequency and risk factors for
elevated cTnT levels were analyzed.
Results: Fourteen patients with a mean age of 54 years (range: 19–87 years) were included. Four patients
(28.6%) had elevated cTnT levels (mean = 0.06 mg/L; range: 0.035–0.076 mg/L). Patients with elevated
cTnT levels were signiﬁcantly older than those with normal levels (77.5 years vs. 45.5 years; P = 0.03). Of
the eight patients 60 years of age and older, four (50%) had elevated cTnT levels. The coronary heart
disease (CHD) score was signiﬁcantly higher in patients with elevated cTnT levels compared to those
with normal levels (13.5 vs. 9.75, P = 0.012).
Conclusions: Elevated troponin levels can occur after a GTC seizure. Patients at risk are the elderly and
those with cardiovascular risk factors. Our results suggest that elevation of troponin levels after a GTC
seizure reﬂects a minor ischemic cardiac injury related to the demand ischemia during the sympathetic
overactivity that accompanies a GTC seizure.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Cardiac troponins are speciﬁc biochemical markers that are
highly sensitive and speciﬁc for the diagnosis of acute myocardial
infarction.1–3 However patients with acute neurological illnesses,
including rare patients who experienced generalized tonic-clonic
(GTC) seizures, were found to have elevations in troponin levels.4–6
Some have speculated that the troponin elevation following a GTC
seizure was secondary to the release of unbound cytosolic troponin
due to increased permeability of myocardial cell membranes,7,8 a
centrally mediated damage to myocytes5 or a false positive
assay,4,8 whereas others have considered this ﬁnding as possibly
indicative of a transient myocardial injury.5 Accordingly, the
current study was designed to evaluate the signiﬁcance of elevated* Corresponding author. Tel.: +961 332290; fax: +961 1370814.
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http://dx.doi.org/10.1016/j.seizure.2013.11.006troponin as assessed by cardiac troponin T (cTnT) levels following a
GTC seizure by comparing the frequency of this ﬁnding in young
versus elderly patients. Furthermore, we hypothesized that
troponin elevation following a GTC seizure would be more
frequent in patients with cardiovascular risk factors.
2. Materials and methods
We reviewed all emergency room admissions to the American
University of Beirut Medical Center over a period of 6 months and
identiﬁed patients who presented with a GTC seizure. The diagnosis
of a GTC was made based on the description of the spell and clear
documentation in the chart of post-ictal confusion. Patients were not
included when the description of the spell was unclear, when
convulsive syncope was a possibility and when there was no
documented evidence of postictal confusion. The medical records of
patients who had a cTnT level drawn within 12 h of their seizure (at
the discretion of the attending physician stafﬁng the emergency
room) were reviewed. Patients with cardiac symptoms, renal
insufﬁciency (creatinine >1.5 mg/dL) or elevated CPK levelsvier Ltd. All rights reserved.
Table 1
Clinical characteristics of the patients.
Patients Age (years) Gender Hx epilepsy Cause of sz Elevated troponin CHD score
1 19 M Yes MTS No
2 21 F Yes cryptogenic No
3 23 F Yes Cortical dysplasia No
4 25 M Yes Cryptogenic No
5 28 M Yes MTS No
6 38 F Yes Cortical dysplasia No
7 62 M Yes Cerebrovascular disease Yes 11
8 64 F No Tumoral No 8
9 73 M Yes Cerebrovascular disease No 11
10 76 M No Cerebrovascular disease No 10
11 77 F No Cerebrovascular disease Yes 14
12 83 F No Alzheimer No 10
13 84 M No Cerebrovascular disease Yes 14
14 87 M No Cerebrovascular disease Yes 15
Hx: history, sz: seizure, MTS: mesial temporal sclerosis.
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Institutional Review Board of the American University of Beirut
Medical Center.cTnT was measured on the Elecsys analyzer (Roche,
Indianapolis, IN) which allows detection of cTnT concentrations as
low as 0.003 mg/L. Based on recent guidelines,9 cTnT levels of
0.035 mg/L and above were considered abnormal. For patients with
cTnT levels of <0.003, a value of 0.003 was assigned for statistical
calculations.
We compared the age of patients with normal and elevated cTnT
levels via a double tailed t test. We tabulated the cardiovascular risk
factors for all patients and calculated the coronary heart disease
(CHD) score for patients aged 60 years and older based on a
previously described model.10 This model is a coronary artery
disease prediction algorithm, developed using categorical variables
including age, cholesterol values, blood pressure, diabetes, and
smoking. Based on those categorical variables, a total score stratiﬁed
by gender can be calculated and was found to be highly predictive for
coronary heart disease risk.10Y 
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Fig. 1. Box and Whisker plot comparing the mean age (1.96*standard error) inCategorical variables for cardiovascular risk factors were
compared between patients with normal and elevated cTnT using
the exact Fisher’s test. The CHD scores for patients 60 years and
older with normal or elevated cTnT levels were compared via a two
tailed t test. All signiﬁcant results were set at a P value <0.05.
3. Results
Fourteen patients (M/F = 8/6) with a mean age of 54.3 years
(range: 19–87 years) were included in this study (Table 1). Eight of
the patients were already diagnosed with epilepsy whereas six
presented with their ﬁrst unprovoked GTC seizure. In patients
younger than 60 years, the most common etiologies were mesial
temporal sclerosis and cortical dysplasia whereas cerebrovascular
disease (remote symptomatic cause) was the cause of seizure/
epilepsy in those older than 60 years (Table 1). The mean initial
cTnT level, drawn on average 2.8 h (range: 0.7–12 h) after the GTC
seizure was 0.021 mg/L (range: 0.003–0.076 mg/L). The meanN
ted  cTnT
 Mean 
 Mean±S E 
 Mean±1.96* SE 
 patients with elevated cTnT to those with normal levels. SE = standard error.
Table 2
Frequency of cardiovascular risk factors in patients with elevated cTnT compared to
those with normal levels.
Risk factor Elevated
cTnT (4 pts)
Normal
cTnT (10 pts)
P (Fisher’s test)
Diabetes 4 0 p = 0.001
HTN 4 1 p = 0.005
Dyslipidemia 4 2 p = 0.015
Smoking 4 2 p = 0.015
CAD 2 0 p = 0.07
Previous MI 2 0 p = 0.07
A. Fawaz et al. / Seizure 23 (2014) 146–150148duration of the GTC seizure, as estimated by witnesses, was
1.7 min (range 1–3 min). The ECG on all patients did not reveal any
evidence of acute ischemic changes.
The cardiovascular risk factors included diabetes in 3 patients,
hypertension in 5 patients, dyslipidemia in 6 patients, smoking in 6
patients, and CAD with previous myocardial infarction in 2
patients. Six patients had no cardiovascular risk factors.
4. Elevated cTnT levels
Four patients (28.6%) had an elevated cTnT level
(mean = 0.06 mg/L, range: 0.035–0.076 mg/L). None of those
patients had symptoms suggestive of myocardial ischemia. The
mean creatinine level for those patients was 0.9 mg/dL (range 0.6–
1.5 mg/dL). Patients with elevated cTnT levels remained asymp-
tomatic throughout their hospital stay and echocardiography failed
to reveal evidence of regional wall motion abnormalities.
Patients with elevated cTnT levels were signiﬁcantly older
(mean: 77.5 years; range 62–87 years) compared to those with
normal levels (mean: 45.5 years; range 19–83 years) (P = 0.03)
(Fig. 1). There was no signiﬁcant difference in the time interval
from the GTC seizure to blood draw between patients with normal
and elevated cTnT levels.
The mean subsequent cTnT levels drawn 40 h (range: 20–58 h)
and 66 h (range: 38–95 h) after the GTC seizure dropped to
0.05 mg/L (range: 0.04–0.073 mg/L) and 0.028 mg/L (range: 0.021–
0.036 mg/L), respectively.
Hypertension, dyslipidemia and smoking were signiﬁcantly
more frequent in patients with high cTnT levels compared to those
with normal levels (Table 2). Although coronary artery disease and
a history of previous myocardial infarction were more common in
the subgroup of patients with elevated cTnT levels, the difference
did not reach statistical signiﬁcance (Table 2).Y 
Elevat
8
9
10
11
12
13
14
15
16
C
H
D
 s
c
o
re
Fig. 2. Box and Whisker plot comparing CHD score (1.96*standard error) in elder5. cTnT levels in elderly
Eight patients (M/F = 5/3) were 60 years and older (mean age:
75 years, range: 62–87 years). Of those, four (50%) had an
elevated cTnT level following their GTC seizure. There was no
signiﬁcant difference in the age of patients with elevated
cTnT levels (mean: 77 years, range: 62–87 years) compared
to those with normal levels (mean age: 74 years, range:
64–83 years).
All four patients with elevated cTnT were diabetics, hyperten-
sive, smokers and had dyslipidemia. In addition two had a history
of coronary artery disease and had suffered from a previous
myocardial infarction. On the other hand, of the four patients with
normal cTnT levels, none was diabetic, one was hypertensive, two
had dyslipidemia and one was a smoker. None had a history of
coronary artery disease or had suffered from previous myocardial
infarction.
The CHD score was signiﬁcantly higher in patients with high
cTnT levels compared to those with normal levels (13.5 vs. 9.75,
P = 0.012) (Fig. 2).N
ed  cTnT 
 Mean 
 Mean±SE 
 Mean±1.96 *SE 
ly patients with elevated cTnT to those with normal levels. SE = standard error.
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Our data indicate that cTnT levels are elevated in some patients
after a GTC seizure. Those patients were signiﬁcantly older
compared to those with troponin levels within the normal range.
In addition, our data show that within the subgroup of elderly
patients, those with elevated cTnT levels had signiﬁcantly higher
CHD scores compared to those with normal levels.
Although cardiac troponins are considered the most accurate
biomarker of myocardial injury in the clinical setting with a high
sensitivity and speciﬁcity,1,2,11 previous studies have documented
troponin elevations in conditions other than acute coronary
syndromes, including but not limited to rhabdomyolysis12 pericar-
ditis, myocarditis, sepsis, advanced renal failure, systemic lupus
erythematosus, and acute CNS injury such as stroke.13–16None of the
patients included in this study suffered from those disorders based
on strict exclusion criterion and review of the medical records.
A few studies evaluated troponin levels following seizures using
sensitive assays. Most of those studies found that the troponin
levels remained within the normal range in all patients prompting
the conclusion that seizures do not result in troponin levels
elevation.3,6,7,17–19 The common denominator across those studies
is that they evaluated young adults3,7,17 or children and
adolescents.18 For instance, in a study of 11 patients admitted
to the epilepsy monitoring unit (4 experienced GTC seizures and 7
complex partial seizures), the mean age of the patients was 34
years with a range between 19 and 55 years.17 Similarly, in another
study that assessed troponin levels following ‘‘uncomplicated
seizures’’ (unclear if these were partial or GTC seizures) in 49
patients with normal cardiac system, the mean age of the
participants was 21 years with a range from 15–62 years.3
Likewise, the troponin levels remained in the normal range after a
GTC seizure in a cohort of 60 patients with a mean age of 44 years
(range not available).7 Our data in patients younger than 60 years
are consistent with those results since none of those had cTnT
elevation after a GTC seizure. However, our data indicate that 50%
of patients older than 60 years of age have cTnT elevation after a
GTC seizure. This age related elevation in cTnT would disfavor the
possibility of a ‘‘normal physiologic release’’ of cytosolic release of
intracellular unbound cardiac enzymes following a GTC seizure,7,8
the possibility of a false positive assay4,8 or the hypothesis of
central nervous system mediated transient myocyte injury as
described in patients with stroke or cerebral hemorrhage5 and
favor the possibility of a minor ischemic cardiac injury likely
related to the perfusion/demand mismatch during the sympathetic
over activity that accompanies a GTC seizure. It is logical to assume
that elderly patients are more prone to a demand ischemia as
compared to younger patients in the setting of a GTC seizure with
the associated apnea, tachycardia, and increased blood pressure
which will result in increased myocardial oxygen consumption.
This hypothesis is further supported by the fact that within the
elderly age group, those with higher CHD scores were signiﬁcantly
more likely to have elevated cTnT levels following a GTC seizure.
Our results are very much consistent with those of a recent
study that documented elevation of troponin in 6.7% of 741
patients following a GTC seizure.19 Although patients with
elevated CPK levels or renal insufﬁciency were not excluded from
the analyses, there was a signiﬁcant association between elevation
of troponin and baseline CPK levels and vascular risk factors
(hypertension, diabetes or dyslipidemia) on logistic regression
analysis. None of the patients with elevated troponin had evidence
of an acute coronary syndrome despite an extensive work-up that
included ECG monitoring, echocardiograms and coronary angio-
grams in a subset of those patients.19
The clinical signiﬁcance of cTnT elevation following a GTC
seizure remains unclear. The absence of cardiac symptoms, normalECG and echocardiography ﬁndings strongly argues against a large
transmural myocardial infarction in any of our patients. Few
isolated case reports of increased troponin levels following a GTC
seizure also failed to document the presence of an acute
myocardial infarction in those patients, despite an extensive
cardiac work-up including coronary angiography.4,5 This supports
the hypothesis that cardiac biochemical markers are more
sensitive than the ECG or echocardiogram in detecting subtle
myocardial injury.15 It is likely that patients with elevated troponin
levels following a GTC seizure and no evidence of acute myocardial
infarct suffered a type 2 myocardial injury due to demand ischemia
secondary to a mismatch between myocardial oxygen demand and
supply in the absence of ﬂow limiting coronary artery stenosis.20 If
the patients suffered only from small subendocardial injury or
necrosis, it might not be detectable as wall motion abnormality by
echocardiography (which requires an infarction thickness of at
least 20% of the myocardium) nor by radionuclide imaging which
has relatively low resolution for detecting small areas of
infarction.21 Since contrast enhanced cardiovascular MRI was
shown to be highly sensitive in detecting subendocardial infarcts
missed by single photon emission computed tomography,22
evaluation of patients with elevated troponin level following a
GTC seizure with this modality will help in conﬁrming this
hypothesis. Furthermore, a contrast enhanced cardiovascular MRI
performed at the time of elevation of troponin levels and repeated
a few weeks later will help differentiate between a reversible
subendocardial ischemia versus necrosis. If persistent cardiac
microlesions are documented, this could favor the onset of cardiac
arrhythmias such as ventricular tachyarrhythmias, which in turn
could facilitate sudden cardiac death as one cause of sudden
unexpected death in epilepsy.23 Of importance is that patients with
elevated troponin levels following an acute neurological illness but
without evidence of myocardial infarction were found to have an
unfavorable outcome.6,15,24 Whether this also applies to patients
with elevated troponin levels following a GTC seizure will have to
be evaluated in prospective longitudinal study.
This study has a number of limitations, in large part due to its
retrospective nature. These include its uncontrolled design, the
small number of patients included, the absence of a control group
(e.g. patients who experienced focal seizures without secondary
generalization), the fact that cTnT levels were not uniformly drawn
in all patients experiencing a GTC seizure, the time interval
variability between the GTC seizure occurrence and the determi-
nation of cTnT levels, and the fact that the cTnT were not assessed
longitudinally when the initial level was within the normal range.
Further prospective longitudinal studies are needed to evaluate the
clinical importance of measuring cTnT levels in the context of GTC
seizures, especially in the elderly with signiﬁcant cardiovascular
risk factors.
7. Conclusion
GTC seizures appear to induce subtle and subclinical cardiac
injury (as assessed by increased cTnT levels) in patients with
cardiovascular risk factors. Although clinicians should be aware
that an elevation in cardiac enzymes in this setting does not
usually indicate the presence of a transmural myocardial infarc-
tion, those patients should be carefully investigated by a
cardiologist and closely followed up, since reports of acute
myocardial infarctions after a GTC seizure have also been
reported.21,25,26
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